Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple ascending dose study of ALKS 7119
NL-OMON27126Not yet recruiting
- Sponsor
- Alkermes
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ALKS 7119 (2 arms), sponsored by Alkermes. Primary endpoint: Safety. Planned start Jul 2016; status: not yet recruiting.
02
Drugs
ALKS 7119
Beyond the preview
Go deeper on NL-OMON27126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27126.